← All Windtree Therapeutics INC /DE/ filings

Windtree Therapeutics INC /DE/ 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
WINT
Windtree Therapeutics INC /DE/
10-K: Windtree Therapeutics Navigates Financial Challenges Amidst Promising Clinical Developments
Windtree Therapeutics reports its 2024 10-K filing, highlighting financial uncertainties alongside progress in its cardiovascular and oncology programs.
OTC.Pink
WINT
Windtree Therapeutics INC /DE/
10-K: Windtree Therapeutics Amends Charter, Issues Preferred Stock and Notes in Strategic Moves
Windtree Therapeutics undertakes several corporate actions including charter amendments, preferred stock issuance, and convertible note offerings to support its ongoing development programs.